News
Chronic Lymphocytic Leukemia Therapeutics Market to Grow at 7% CAGR Driven by Targeted Drugs by 2030
The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...
InvestorsHub on MSN8m
GSK shares rise after FDA grants priority review for oral gonorrhea antibiotic
GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback